Skip to main content

Peer Review reports

From: Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study

Original Submission
12 Jul 2010 Submitted Original manuscript
26 Jul 2010 Reviewed Reviewer Report - Jozelio Carvalho
17 Aug 2010 Reviewed Reviewer Report - Cemalettin Aybay
8 Sep 2010 Reviewed Reviewer Report - Patrick Durez
8 Nov 2010 Author responded Author comments - Bart Van den Bemt
Resubmission - Version 2
8 Nov 2010 Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
17 Nov 2010 Reviewed Reviewer Report - Jozelio Carvalho
24 Nov 2010 Reviewed Reviewer Report - Cemalettin Aybay
12 Jan 2011 Author responded Author comments - Bart Van den Bemt
Resubmission - Version 4
12 Jan 2011 Submitted Manuscript version 4
Publishing
13 Jan 2011 Editorially accepted
13 Jan 2011 Article published 10.1186/1471-2474-12-12

You can find further information about peer review here.

Back to article page